Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Medicines Australia Lays Down Challenge On New PBS Listings For Next Government As September Polls Loom

This article was originally published in PharmAsia News

Executive Summary

The association that represents multinational pharmaceutical companies in Australia is challenging the next government ahead of elections to move quicker to subsidize approved new drugs under the country’s universal health care system, saying access to drugs has been sharply curtailed.


Related Content

Battle Over Deferred Drug Listings In Australia: Should Cost-Effective Drugs Always Be Funded?


Related Companies




Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts